Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]
Cancers (Basel)Chen P +3 more
europepmc +1 more source
Bringing enzymes to the proximity party. [PDF]
RSC Chem Biol, 2023 Tender GS, Bertozzi CR.
europepmc +1 more source
Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]
Iran J BiotechnolSaadatkhah F +4 more
europepmc +1 more source
Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds". [PDF]
Front PharmacolRashad Y +4 more
europepmc +1 more source
Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861. [PDF]
Front Pharmacol, 2023 Masilamani AP +10 more
europepmc +1 more source
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from <i>Pseudomonas aeruginosa</i> exotoxin A. [PDF]
Front Vet SciAndré AS +16 more
europepmc +1 more source
Targeting the CD47-TSP1 Axis in Abdominal Aortic Aneurysm: A Novel Immunotherapeutic Approach. [PDF]
Int J Mol SciStępień KL, Janas K, Rojek S.
europepmc +1 more source
Next generation of "magic bullets", solutions from the microbial pangenome. [PDF]
EMBO Mol MedMasignani V, Rappuoli R, Pizza M.
europepmc +1 more source